NEWBURYPORT, Mass. - UFP Technologies, Inc. (NASDAQ:UFPT), a key player in the design and manufacturing of medical devices and custom products, announced today the acquisition of Marble Medical, a Florida-based specialist in adhesive-based medical components and devices. This strategic move is expected to enhance UFP's product offerings in the medical technology sector.
Marble Medical, established in 1988, is recognized as a 3M Preferred Converter and is known for its precision die cutting capabilities. The integration of Marble Medical's expertise is anticipated to complement UFP's existing products, such as surgical robot drapes and skin-adhesive devices.
According to R. Jeffrey Bailly, chairman and CEO of UFP Technologies, the acquisition will provide clients with a more comprehensive range of innovative solutions utilizing advanced adhesive technologies.
The synergy between the two companies is further underscored by Marble Medical's history as a partner to UFP's DAS Medical operation. Bailly expressed confidence that the acquisition would fit seamlessly into UFP's MedTech business and support their strategic focus, offering significant technologies across multiple markets.
Joe Audie, president of Marble Medical, shared his optimism about joining UFP Technologies, citing the potential for accelerated growth through UFP's extensive resources and global manufacturing footprint. The merger aims to leverage Marble Medical's biocompatible adhesives expertise in areas such as diagnostic patches, wound care, and other applications that involve adherence to the skin.
UFP Technologies serves as a critical link in the medical device supply chain, providing single-use devices and components for a variety of medical applications, including minimally invasive surgery, infection prevention, and orthopedics.
The press release also included forward-looking statements regarding the expected financial performance and future business prospects following the acquisition. It highlighted the anticipated benefits for both UFP Technologies and Marble Medical, as well as the potential for growth in various markets and customer demand. However, investors are cautioned about the inherent risks and uncertainties that may affect the anticipated outcomes.
This news is based on a press release statement from UFP Technologies, Inc. As with any business development, the actual results may differ from the expectations outlined in the forward-looking statements.
In other recent news, UFP Technologies has made significant strides with its recent acquisition of AJR Enterprises for $110 million. The acquisition is expected to enhance UFP Technologies' offerings in the medical market and aligns with its growth strategy. AJR Enterprises, known for its advanced fabric technologies, reported sales of around $75 million for the trailing 12-month period ending March 31, 2024, and an adjusted EBITDA of approximately $18.3 million.
Lake Street Capital Markets has adjusted its outlook on UFP Technologies, increasing the price target to $344, and maintaining a Buy rating. The firm projects that UFP Technologies is on track to achieve a GAAP Earnings Per Share (EPS) of $9 by 2026 and forecasts the potential to surpass $10 in 2027.
KeyBanc has retained its Sector Weight rating on UFP Technologies following the acquisition, citing valuation reasons. These recent developments underscore UFP Technologies' commitment to executing its growth strategy and meeting its financial targets, which include a revenue growth rate of 12%-18%, a gross margin range of 28%-31%, and an operating margin between 15%-18%.
InvestingPro Insights
As UFP Technologies, Inc. (NASDAQ:UFPT) expands its presence in the medical technology sector with the acquisition of Marble Medical, investors are closely watching the company's performance metrics. According to real-time data from InvestingPro, UFP Technologies boasts a robust market capitalization of 2.45 billion USD, reflecting investor confidence in the company's growth trajectory.
The company's Price/Earnings (P/E) Ratio stands at 51.09, indicating a premium market valuation, which aligns with the company's strategic moves to enhance its product offerings. Furthermore, the Price/Book (P/B) ratio is at 8.3, suggesting that the market values the company's assets highly relative to its book value.
InvestingPro Tips reveal that analysts have revised their earnings upwards for the upcoming period, signaling optimism about the company's financial outlook post-acquisition. Additionally, UFP Technologies has been trading near its 52-week high, with a price that is 99.35% of this peak, reflecting strong market sentiment and the potential for sustained growth.
For investors looking to delve deeper into UFP Technologies' financials and future outlook, InvestingPro offers a wealth of additional tips. There are currently 19 more InvestingPro Tips available, providing a comprehensive analysis of the company's performance and potential investment opportunities. Interested readers can access these tips on InvestingPro's platform and use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, enhancing their investment research with valuable insights.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.